PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsNephrotic syndrome
MeSH D009404 - nephrotic syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009401:Nephrosis
0 Companies
0 Drugs
Success rate
D009404: 
Nephrotic syndrome
190 Companies
70 Drugs
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
71%
5/7
Phase 2
38%
8/21
Phase 3
88%
36/41
Approved: 25Overall Success rate: 24%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Amlodipine besylate,
Cyclophosphamide,
Hydrochlorothiazide,
Losartan potassium,
Methylprednisolone,
Moexipril,
Prednisolone,
Prednisolone tebutate,
Prednisone
Dr Reddys Laboratories
Hydrochlorothiazide
Mylan
Benazepril,
Hydrochlorothiazide,
Losartan potassium,
Metolazone,
Metoprolol,
Nystatin,
Quinapril
GSK
Hydrochlorothiazide,
Labetalol,
Albumin,
Bevifimod
Roche
Terfenadine,
Aspartame,
Nepidermin,
Solumedrol,
Sominex
1
2
3
4
5
6
...
13
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use